蛋白质化,肝脏代谢和肝脏疾病
Shuang Liu1, Rui Li2, Ya-Wen Sun2
1College of Animal Science and Veterinary Medicine, Shandong Agricultural University, Tai'an 271018, Shandong Province, China.
World journal of hepatology
|April 5, 2024
概括
蛋白质化,一个关键的修改,影响肝脏代谢和疾病. 向化通路为肝脏疾病 (如脂肪肝和癌症) 提供了一个有前途的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 代谢学 代谢学 代谢学
背景情况:
- 糖化是一种保留的翻译后修饰,影响蛋白质稳定性和酶活性.
- 蛋白质化在肝脏中很普遍,与肝脏代谢有关,包括糖解,尿素循环和脂质代谢.
研究的目的:
- 讨论化对肝脏葡萄糖,氨基酸和脂质代谢的影响.
- 审查糖酶在肝病进展中的作用,包括脂肪肝病,肝炎和肝细胞癌.
主要方法:
- 关于蛋白质化及其酶调节的现有文献的综述.
- 分析特定酶的参与,如氨酸转移酶1,氨酸5,氨酸7和氨酸转移酶2A在化通路中的参与.
主要成果:
- 糖化显著影响肝脏代谢途径.
- 顺化失调与各种肝病的发病有关,包括脂肪肝,肝炎和肝细胞癌.
结论:
- 准蛋白质糖化通路为肝脏疾病提供了一个新的治疗途径.
- 对化机制的进一步研究可能会导致肝脏疾病的有效治疗方法.
相关概念视频
Phase II Reactions: Acetylation Reactions
223
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
223
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
224
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
224
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Overview of Lipid Metabolism
1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K
Liver Physiology
538
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
538
Inborn Errors of Metabolism
157
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
157


